Effectiveness of the Spot Vision Screener With Variations in Ocular Pigments.

Purpose: To evaluate Spot in detecting American Association for Pediatric Ophthalmology and Strabismus (AAPOS) Amblyopia risk factors (ARF) and for ARF myopia and hyperopia with variations in ocular pigments.

Design: Diagnostic screening test evaluation.

Methods: Study population: Children presented for a complete eye examination in pediatric clinic.

Prescribing patterns for paediatric hyperopia among paediatric eye care providers.

Purpose: To survey paediatric eye care providers to identify current patterns of prescribing for hyperopia.

Methods: Paediatric eye care providers were invited, via email, to participate in a survey to evaluate current age-based refractive error prescribing practices. Questions were designed to determine which factors may influence the survey participant's prescribing pattern (e.

The blinq™ Vision Screener in Detection of Amblyopia and Strabismus.

Purpose: The blinq (Rebion Inc) is a new screening device designed to directly detect amblyopia and strabismus rather than amblyopia risk factors. We performed an independent assessment of the effectiveness of the blinq in detecting amblyopia and strabismus.

Design: Prospective clinical validity analysis of a screening device based on sensitivity and specificity.

Effectiveness of the Spot Vision Screener using updated 2021 AAPOS guidelines.

Purpose: To evaluate the Spot Vision Screener according to updated 2021 AAPOS Vision Screening Committee guidelines for instrument-based pediatric vision screen validation.

Methods: As part of an IRB-approved ongoing prospective study, children were screened with the Spot prior to a complete examination.

Results: Spot screening was successful in 1,036 of 1,090 children (95%).

Inherited Retinal Dystrophy in Southeastern United States: Characterization of South Carolina Patients and Comparative Literature Review.

Inherited retinal dystrophies (IRDs) are a group of rare diseases involving more than 340 genes and a variety of clinical phenotypes that lead to significant visual impairment. The aim of this study is to evaluate the rates and genetic characteristics of IRDs in the southeastern region of the United States (US). A retrospective chart review was performed on 325 patients with a clinical diagnosis of retinal dystrophy.

AAPOS uniform guidelines for instrument-based pediatric vision screen validation 2021.

Background: As instrument-based pediatric vision screening technology has evolved, the American Association for Pediatric Ophthalmology and Strabismus (AAPOS) has developed uniform guidelines (2003, updated 2013) to inform the development of devices that can detect specified target levels of amblyopia risk factors (ARFs) and visually significant refractive error. Clinical experience with the established guidelines has revealed an apparent high level of over-referral for non-amblyopic, symmetric astigmatism, prompting the current revision.

Methods: The revised guidelines reflect the expert consensus of the AAPOS Vision Screening and Research Committees.

Evaluation of the Spot Vision Screener in School-Aged Children.

Purpose: To determine the accuracy of the Spot Vision Screener (Welch Allyn, Skaneateles Falls, NY) in children 6 years and older and recommend device thresholds to improve its accuracy for the detection of refractive error.

Methods: The Spot Vision Screener results were compared with three gold standard conditions of increasingly narrow refractive error criterion. The sensitivity, specificity, positive predictive value, and negative predictive value of the Spot Vision Screener in detecting each gold standard criterion were calculated.

Effectiveness of the iPhone GoCheck Kids smartphone vision screener in detecting amblyopia risk factors.

Background: The recently released GoCheck Kids iPhone photoscreening app is designed to detect amblyopia risk factors (ARFs) in young children and includes remote review of images captured by smartphone. We aimed to evaluate the system's accuracy in detecting AAPOS guidelines ARFs.

Methods: Patients 6 months through 6 years of age at Medical University of South Carolina were recruited for this prospective study.

A high prevalence of biallelic RPE65 mutations in Costa Rican children with Leber congenital amaurosis and early-onset retinal dystrophy.

Background: Leber congenital amaurosis (LCA) and early-onset retinal dystrophy (EORD), are primary causes of inherited childhood blindness. Both are autosomal recessive diseases, with mutations in more than 25 genes explaining approximately ~70% of cases. However, the genetic cause for many cases remains unclear.

Effectiveness of the GoCheck Kids Vision Screener in Detecting Amblyopia Risk Factors.

Purpose: The GoCheck Kids smartphone photoscreening app (Gobiquity Mobile Health, Scottsdale, Arizona, USA), introduced in 2014, is marketed to pediatricians with little published validation. We wished to evaluate the GoCheck Kids Screener for accuracy in detecting amblyopia risk factors (ARF) using 2013 American Association for Pediatric Ophthalmology and Strabismus guidelines.

Design: Validity assessment.

Use of the Spot Vision Screener for patients with developmental disability.

Purpose: To determine whether the Spot Vision Screener effectively detects amblyopia risk factors (ARFs) in patients with developmental disability using the 2013 guidelines of the American Association for Pediatric Ophthalmology and Strabismus (AAPOS).

Methods: Children with developmental disability presenting for complete pediatric ophthalmologic examination were prospectively enrolled between June 2012 and March 2016. The following data were analyzed: presence of ARFs according to the AAPOS guidelines, refraction, eye alignment, and other ocular pathology.

Retinopathy of prematurity: screening and treatment in Costa Rica.

Aim: To determine the recent demographic data, risk factors and results of retinopathy of prematurity (ROP) screening and treatment in Costa Rica.

Methods: The medical records of all preterm infants meeting ROP screening criteria (≤34 weeks' gestational age (GA) or birth weight (BW) ≤1750g, and those determined at risk by neonatologists) in the national healthcare system, Costa Rica, January 2010-December 2014, were retrospectively reviewed. The numbers and percentages of infants with ROP, risk factors, percentage of patients treated and treatment outcomes were determined.

Performance of the Spot Vision Screener in Children Younger Than 3 Years of Age.

Purpose: To evaluate the use of the Spot Vision Screener (Spot; Welch Allyn, Skaneateles Falls, New York, USA) for detection of amblyopia risk factors in children aged 6 months to 3 years, as defined by the 2013 guidelines of the American Association for Pediatric Ophthalmology and Strabismus.

Design: Reliability analysis.

Methods: In this study, children seen from June 1, 2012, to April 30, 2016 were tested with the Spot during a routine visit.

Detecting High Hyperopia: The Plus Lens Test and the Spot Vision Screener.

Purpose: To evaluate the usefulness of the Plus Lens (Goodlite Company, Elgin, IL) test and the Spot Vision Screener (Welch Allyn, Skaneateles Falls, NY) in detecting high hyperopia in a pediatric population.

Methods: Between June and August 2015, patients were screened with the Spot Vision Screener and the Plus Lens test prior to a scheduled pediatric ophthalmology visit. The following data were analyzed: demographic data, Plus Lens result, Spot Vision Screener result, cycloplegic refraction, and examination findings.

Prospective Evaluation of Photoscreeners in the Pseudophakic Eyes of Children.

Purpose: To compare refractive data of Plusoptix AO9 (Plusoptix, Inc., Atlanta, GA) and Spot (Welch Allyn, Skaneateles Falls, NY) photoscreeners with retinoscopy in pseudophakic eyes of children.

Methods: In this prospective study, patients underwent testing with the Plusoptix and Spot photoscreeners prior to their examination by a pediatric ophthalmologist masked to the results of both photoscreeners.

Detection of strabismus by the Spot Vision Screener.

Background: The Spot Vision Screener, a new automated screener designed for use in schools and pediatric offices, refers children for strabismus based on the device's measurement of "gaze." We sought to evaluate its ability to detect manifest strabismus of ≥8(Δ) in primary position, which criteria is specified by the 2013 guidelines of the American Association for Pediatric Ophthalmology and Strabismus for detection of amblyopia risk factors by automated vision screeners.

Methods: In this prospective study, new and returning patients seen in the pediatric ophthalmology clinic underwent screening with the Spot Vision Screener (version 1.

Evaluation of the Spot Vision Screener in young children in Costa Rica.

Background: The Spot Vision Screener has demonstrated good sensitivity and specificity in the pediatric ophthalmology clinic setting. We sought to evaluate the updated Spot (version 2.0.

The effectiveness of the Spot Vision Screener in detecting amblyopia risk factors.

Purpose: To evaluate the updated Spot Vision Screener (PediaVision, Welch Allyn, Skaneateles Falls, NY) in detecting amblyopia risk factors using 2013 guidelines of American Association for Pediatric Ophthalmology and Strabismus (AAPOS).

Methods: In this prospective study, patients seen from June 2012 to November 2013 were tested with the Spot prior to examination by a pediatric ophthalmologist who was masked to test results. The following data were analyzed: age, subject testability, examination findings, and systemic and ocular pathology.

Combining automated vision screening with on-site examinations in 23 schools: ReFocus on Children Program 2012 to 2013.

Purpose: The Association for the Blind and Visually Impaired (ABVI) began the ReFocus on Children Program to assist school nurses in providing vision screening for at-risk children in the Charleston County School District in South Carolina.

Methods: In 2012 to 2013, 2,750 low-income school children ages 3 to 5 years were screened using the Plusoptix Vision screener (Atlanta, GA). Further examinations were performed on 419 (56%) children referred and glasses prescribed and provided for 192 children (positive predictive value 46%).

Photoscreeners in the pediatric eye office: compared testability and refractions on high-risk children.

Purpose: To compare refractive data and testability of Spot (PediaVision) and Plusoptix A09 (Plusoptix, Inc) photoscreeners and to compare each device with traditional cycloplegic retinoscopy.

Design: Prospective, interventional case series.

Methods: After informed consent, patients underwent testing with the Spot and Plusoptix photoscreeners before their examination by a pediatric ophthalmologist masked to the results.

A pilot study evaluating the use of EyeSpy video game software to perform vision screening in school-aged children.

Purpose: To compare the vision-screening results of school-aged children tested with EyeSpy software and those of children examined by a pediatric ophthalmologist. We also compared combined results of an electronic visual acuity (EVA) tester and stereopsis testing to the results of a professional eye examination.

Methods: In this pilot study, all children were tested with an EyeSpy and ETDRS EVA tester, followed by ocular examination including stereopsis assessment and cyclopegic refraction.

New techniques and technologies for pediatric cataract surgery.

Purpose Of Review: This paper surveys the literature from April 2004 to April 2005 and addresses trends in pediatric cataract surgery techniques.

Recent Findings: The evolution of pediatric cataract surgery continues, with many adult cataract surgical techniques being applied to children with minor technical adjustments. More and more, surgeons are implanting intraocular lenses in younger children.

Interocular axial length difference in eyes with pediatric cataracts.

Purpose: We sought to report interocular axial length difference (IALD) between the operated eye and fellow eye at the time of pediatric cataract surgery.

Methods: A retrospective analysis of 171 cataractous (operated) eyes (mean patient age at surgery, 56.9 months; range, 0.